PharmiWeb.com - Global Pharma News & Resources
02-Apr-2019

MOLOGEN AG: Successful completion of capital increase with substantial oversubscription

DGAP-News: MOLOGEN AG / Key word(s): Corporate Action


The issuer is solely responsible for the content of this announcement.




02.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MOLOGEN AG
Fabeckstra├če 30
14195 Berlin
Germany
Phone: 030 / 841788-0
Fax: 030 / 841788-50
E-mail: presse@mologen.com
Internet: www.mologen.com
ISIN: DE000A2LQ900
WKN: A2LQ90
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 794805

 
End of News DGAP News Service

Editor Details

Last Updated: 02-Apr-2019